Grace Therapeutics, Inc. (GRCE)
SG&A Expense Growth
446.68%
Quarterly · Period ending:
GRCE SG&A Expense Growth
Latest reported446.68%period ending
Latest reported446.68%period ending
GRCE Quarterly SG&A Growth (QoQ) (0.00% → 446.68%)
Latest values, visible window
High-resolution chart · PNG
GRCE sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 446.6818% | |
| -88.6701% | |
| -0.3655% | |
| 28.1608% | |
| -3.1818% | |
| 1.5217% | |
| 17.1115% | |
| -39.8891% | |
| 47.2223% | |
| -1.2694% | |
| -3.9824% | |
| -10.8884% | |
| -27.1627% | |
| 42.6842% | |
| 30.4686% | |
| -32.2002% | |
| 3.8926% | |
| -0.477% | |
| -30.9876% | |
| -7.6858% | |
| 71.872% | |
| 9.7389% | |
| -15.6442% | |
| -40.8643% | |
| 16.1109% | |
| 67.7095% | |
| -2.9118% | |
| 26.707% | |
| 8.8323% | |
| 96.9424% | |
| -16.4371% | |
| 28.7176% | |
| -17.6778% | |
| 39.1051% | |
| -17.6325% | |
| 32.9416% | |
| 0% | |
| -5.6389% | |
| 50.6812% | |
| 141.777% | |
| -388.7618% | |
| -5.2432% | |
| -25.2642% | |
| -22.5132% | |
| -38.4969% | |
| -29.986% | |
| -7.2911% | |
| 33.4974% | |
| -36.1946% | |
| 9.9828% | |
| 50.1237% | |
| 20.896% | |
| -7.6638% | |
| -5.0709% | |
| 6.2503% | |
| -17.6337% | |
| 52.8828% | |
| -5.7309% | |
| 33.1936% | |
| 125.0032% | |
| -31.3779% | |
| 32.5403% | |
| 14.9851% | |
| 89.6135% | |
| 50.6832% | |
| 0.0718% | |
| 59.2424% | |
| 0% | |
| 0% |